Display options
Share it on

J Clin Transl Hepatol. 2015 Mar;3(1):42-52. doi: 10.14218/JCTH.2014.00032. Epub 2015 Mar 15.

Update on Autoimmune Hepatitis.

Journal of clinical and translational hepatology

Rodrigo Liberal, Diego Vergani, Giorgina Mieli-Vergani, Downer

Affiliations

  1. Paediatric Liver, GI & Nutrition Centre and Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, London, UK.

PMID: 26357634 PMCID: PMC4542083 DOI: 10.14218/JCTH.2014.00032

Abstract

Autoimmune hepatitis (AIH), a liver disorder affecting both children and adults, is characterized by inflammatory liver histology, elevated transaminase levels, circulating nonorganspecific autoantibodies, and increased levels of immunoglobulin G, in the absence of a known etiology. Two types of AIH are recognized according to seropositivity: smooth muscle antibody and/or antinuclear antibody define AIH type 1 and antibodies to liver-kidney microsome type 1 and/or liver cytosol type 1 define AIH type 2. AIH type 1 affects both adults and children, while AIH type 2 is mainly a paediatric disease, though it does occasionally affects young adults. AIH should be considered during the diagnostic workup of any patient with increased liver enzyme levels. AIH is exquisitely responsive to immunosuppressive treatment with prednisolone with or without azathioprine, with symptom free long-term survival for the majority of patients. For those who do not respond to standard treatment, or who are difficult-to-treat, mycophenolate mofetil and, in the absence of a response, calcineurin inhibitors should be tried in addition to steroids. The pathogenesis of AIH is not fully understood, although there is mounting evidence that genetic susceptibility, molecular mimicry and impaired immunoregulatory networks contribute to the initiation and perpetuation of the autoimmune attack. Liver damage is thought to be mediated primarily by CD4 T-cells, although recent studies support the involvement of diverse populations, including Th17 cells. A deeper understanding of the pathogenesis of AIH is likely to contribute to the development of novel treatments, such as the adoptive transfer of autologous expanded antigenspecific regulatory T-cells, which ultimately aim at restoring tolerance to liver-derived antigens.

Keywords: Autoantibodies; Autoimmune hepatitis; Immunogenetics; Immunosuppresion; Regulatory T cells

References

  1. J Hepatol. 2011 Jul;55(1):171-82 - PubMed
  2. Gastroenterology. 2014 Aug;147(2):443-52.e5 - PubMed
  3. Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):653-64 - PubMed
  4. Hepatology. 2002 Mar;35(3):658-64 - PubMed
  5. Arthritis Rheum. 1993 Jun;36(6):836-41 - PubMed
  6. PLoS One. 2011 Apr 19;6(4):e18909 - PubMed
  7. Clin Exp Immunol. 1973 Nov;15(3):331-44 - PubMed
  8. J Hepatol. 2013 Mar;58(3):529-34 - PubMed
  9. Gastroenterology. 1994 Sep;107(3):799-804 - PubMed
  10. Dig Dis Sci. 1996 Feb;41(2):305-14 - PubMed
  11. Tissue Antigens. 2007 Mar;69(3):227-35 - PubMed
  12. J Hepatol. 2004 Jul;41(1):31-7 - PubMed
  13. J Clin Pathol. 1991 Feb;44(2):107-14 - PubMed
  14. J Hepatol. 1999 Nov;31(5):929-38 - PubMed
  15. Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31 - PubMed
  16. Hepatology. 2009 Jul;50(1):130-42 - PubMed
  17. J Immunol. 2006 Apr 1;176(7):4484-91 - PubMed
  18. Hepatology. 2010 Jun;51(6):2193-213 - PubMed
  19. Hepatology. 2010 Dec;52(6):2246-7 - PubMed
  20. Nature. 2006 May 11;441(7090):235-8 - PubMed
  21. J Autoimmun. 2013 Mar;41:126-39 - PubMed
  22. J Autoimmun. 2010 Feb;34(1):7-14 - PubMed
  23. Am J Gastroenterol. 2002 Sep;97(9):2402-7 - PubMed
  24. Hepatology. 2011 Feb;53(2):517-26 - PubMed
  25. Hepatology. 2012 Aug;56(2):677-86 - PubMed
  26. Gastroenterol Hepatol. 2004 Apr;27(4):239-43 - PubMed
  27. N Engl J Med. 2006 Jan 5;354(1):54-66 - PubMed
  28. Hepatology. 1993 Oct;18(4):998-1005 - PubMed
  29. Ann N Y Acad Sci. 1965 Jun 30;124(2):767-80 - PubMed
  30. Clin Transpl. 2004;:315-29 - PubMed
  31. Clin Exp Immunol. 2000 Aug;121(2):364-74 - PubMed
  32. Hepatology. 1997 Aug;26(2):459-66 - PubMed
  33. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):158-64 - PubMed
  34. N Engl J Med. 2009 Aug 27;361(9):888-98 - PubMed
  35. Hepatology. 1988 Nov-Dec;8(6):1662-6 - PubMed
  36. Clin Liver Dis. 2002 Aug;6(3):623-34 - PubMed
  37. J Clin Pathol. 1976 May;29(5):403-10 - PubMed
  38. J Hepatol. 1993 Aug;19(1):55-63 - PubMed
  39. Lancet. 1987 Feb 7;1(8528):292-4 - PubMed
  40. World J Gastroenterol. 2011 Apr 28;17(16):2070-5 - PubMed
  41. N Engl J Med. 1995 Oct 12;333(15):958-63 - PubMed
  42. Hepatology. 2006 Mar;43(3):532-8 - PubMed
  43. J Chronic Dis. 1980;33(6):375-81 - PubMed
  44. Hepatology. 1999 Oct;30(4):851-6 - PubMed
  45. Clin Gastroenterol Hepatol. 2012 Apr;10(4):346-53 - PubMed
  46. Clin Pediatr (Phila). 2004 Sep;43(7):637-42 - PubMed
  47. World J Gastroenterol. 2008 Jun 7;14(21):3388-95 - PubMed
  48. Clin Exp Immunol. 2009 Aug;157(2):261-70 - PubMed
  49. J Hepatol. 2006 Oct;45(4):575-83 - PubMed
  50. J Hepatol. 2011 Feb;54(2):340-7 - PubMed
  51. Hepatology. 2003 Jul;38(1):196-202 - PubMed
  52. Gastroenterology. 2010 Jul;139(1):58-72.e4 - PubMed
  53. Gastroenterology. 2010 Oct;139(4):1198-206 - PubMed
  54. World J Gastroenterol. 2008 Jun 7;14(21):3374-87 - PubMed
  55. Hepatology. 2001 Mar;33(3):544-53 - PubMed
  56. Semin Liver Dis. 2002 Nov;22(4):317-24 - PubMed
  57. Gastroenterology. 1994 Jul;107(1):200-7 - PubMed
  58. J Hepatol. 2006 Dec;45(6):844-50 - PubMed
  59. Q J Med. 1971 Apr;40(158):159-85 - PubMed
  60. World J Gastroenterol. 2008 Jun 7;14(21):3301-5 - PubMed
  61. Case Rep Gastroenterol. 2010 Nov 23;4(3):502-509 - PubMed
  62. Hepatology. 2002 Jan;35(1):7-13 - PubMed
  63. Am J Gastroenterol. 2004 Jul;99(7):1316-20 - PubMed
  64. Arch Dis Child. 1992 Dec;67(12):1447-53 - PubMed
  65. Clin Exp Immunol. 1984 Feb;55(2):347-54 - PubMed
  66. Aliment Pharmacol Ther. 2006 May 1;23(9):1347-53 - PubMed
  67. Hepatology. 1990 Aug;12(2):224-32 - PubMed
  68. Semin Liver Dis. 2009 Aug;29(3):273-85 - PubMed
  69. Dig Dis Sci. 1997 Aug;42(8):1688-96 - PubMed
  70. Liver Transpl. 2007 Jul;13(7):996-1003 - PubMed
  71. Expert Opin Pharmacother. 2011 Mar;12(4):607-13 - PubMed
  72. Arthritis Rheum. 1997 Sep;40(9):1601-11 - PubMed
  73. Hepatology. 2000 Jan;31(1):49-53 - PubMed
  74. J Gastroenterol Hepatol. 2010 Oct;25(10):1681-6 - PubMed
  75. Liver Transpl. 2013 Oct;19(10):1065-77 - PubMed
  76. Hepatology. 1995 Jan;21(1):58-62 - PubMed
  77. Adv Immunol. 1989;44:93-151 - PubMed
  78. Clin Med (Lond). 2007 Apr;7(2):119-24 - PubMed
  79. Lancet. 1956 Dec 29;271(6957):1323-6 - PubMed
  80. Lancet. 1990 Feb 3;335(8684):258-9 - PubMed
  81. Semin Liver Dis. 2002 Nov;22(4):339-52 - PubMed
  82. J Autoimmun. 2005 Aug;25(1):63-71 - PubMed
  83. Autoimmunity. 2002 Dec;35(8):497-500 - PubMed
  84. Hepatology. 2008 Jul;48(1):169-76 - PubMed
  85. J Hepatol. 2012 Jul;57(1):125-32 - PubMed
  86. J Hepatol. 1997 Jun;26(6):1207-12 - PubMed
  87. J Hepatol. 1996 Dec;25(6):859-66 - PubMed
  88. Semin Immunopathol. 2009 Sep;31(3):421-35 - PubMed
  89. Gut. 1995 May;36(5):749-54 - PubMed
  90. Semin Liver Dis. 2009 Aug;29(3):241-53 - PubMed
  91. J Hepatol. 2004 Oct;41(4):677-83 - PubMed
  92. Gut. 1998 May;42(5):721-6 - PubMed
  93. Scand J Gastroenterol. 1998 Jan;33(1):99-103 - PubMed
  94. Gut. 2009 Jan;58(1):152-3 - PubMed
  95. Am J Gastroenterol. 2004 Aug;99(8):1510-6 - PubMed
  96. Hepatology. 2000 Oct;32(4 Pt 1):693-700 - PubMed
  97. J Immunol Methods. 1993 Feb 26;159(1-2):1-16 - PubMed
  98. Gastroenterology. 1999 Mar;116(3):643-9 - PubMed
  99. Hepatology. 2010 Sep;52(3):999-1007 - PubMed
  100. Aliment Pharmacol Ther. 2010 Apr;31(8):771-87 - PubMed
  101. Hepatology. 2006 Feb;43(2 Suppl 1):S132-44 - PubMed
  102. Lancet. 1973 Apr 7;1(7806):735-7 - PubMed
  103. Lancet. 2000 Apr 29;355(9214):1510-5 - PubMed
  104. Gastroenterology. 1972 Nov;63(5):820-33 - PubMed

Publication Types